A preoperative radiogenomic model based on quantitative heterogeneity for predicting outcomes in triple-negative breast cancer patients who underwent neoadjuvant chemotherapy.
Jiayin ZhouYansong BaiYing ZhangZezhou WangShiyun SunLuyi LinYajia GuChao YouPublished in: Cancer imaging : the official publication of the International Cancer Imaging Society (2024)
Multiscale heterogeneity characterized by DCE-MRI could effectively predict the pCR and prognosis of TNBC patients. The radiogenomic model could serve as a valuable biomarker to improve the prediction performance.
Keyphrases
- neoadjuvant chemotherapy
- end stage renal disease
- single cell
- locally advanced
- newly diagnosed
- contrast enhanced
- lymph node
- ejection fraction
- magnetic resonance imaging
- chronic kidney disease
- peritoneal dialysis
- sentinel lymph node
- patients undergoing
- high resolution
- squamous cell carcinoma
- magnetic resonance
- patient reported outcomes
- rectal cancer
- early stage
- adipose tissue
- weight loss
- glycemic control